Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amantadine in bipolar depression
IRCT20100127003210N32Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial in bipolar disorder (BD) comparing Amantadine with Placebo (2 arms). Primary endpoints: HAM-D score and WHOQOL-BREF score. Started Jul 2025; status: completed.
02
Drugs
amantadine
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on IRCT20100127003210N32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20100127003210N32.